Bioventus Inc (BVS) — Capital Reinvestment Ratio
Bioventus Inc (BVS) has a Capital Reinvestment Ratio of 0.06x as of March 2026, meaning it reinvests 0% of its operating cash flow ($8.93 Million) in capital expenditures ($574.00K). See BVS net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bioventus Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks Bioventus Inc's Capital Reinvestment Ratio across 10 annual periods. Check Bioventus Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bioventus Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for Bioventus Inc from 2013 to 2025. For live market cap and broader valuation context, see Bioventus Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $73.98 Million | $2.56 Million | ▲ +33.6% |
| 2024 | 0.03x | $38.80 Million | $1.01 Million | ▼ -94.6% |
| 2023 | 0.48x | $15.34 Million | $7.36 Million | ▲ +49.7% |
| 2021 | 0.32x | $22.99 Million | $7.37 Million | ▲ +11.3% |
| 2020 | 0.29x | $71.80 Million | $20.67 Million | ▲ +40.5% |
| 2019 | 0.20x | $40.71 Million | $8.34 Million | ▲ +52.8% |
| 2018 | 0.13x | $45.19 Million | $6.06 Million | ▼ -65.9% |
| 2015 | 0.39x | $18.92 Million | $7.44 Million | ▼ -71.5% |
| 2014 | 1.38x | $15.11 Million | $20.83 Million | ▼ -40.4% |
| 2013 | 2.31x | $2.75 Million | $6.36 Million | — |